Introduction Gestational diabetes is a major burden for women and maternal care systems all over the world.1 More than 90% of the global prevalence is estimated to be in low-income and middle-income countries (LMICs), where access to diagnosis and monitoring care remains limited.2 Although controversy still exists on the method and timing of screening and the thresholds for diagnosis,3–6 most international and national guidelines recommend using a 75 g oral glucose tolerance test (OGTT) at...